Can explicit suggestions about the harmfulness of EMF exposure exacerbate a nocebo response in healthy controls? by Verrender, Adam et al.
University of Wollongong
Research Online
Faculty of Social Sciences - Papers Faculty of Social Sciences
2018
Can explicit suggestions about the harmfulness of
EMF exposure exacerbate a nocebo response in
healthy controls?
Adam Verrender
University of Wollongong, av138@uowmail.edu.au
Sarah P. Loughran
University of Wollongong, loughran@uow.edu.au
Anna Dalecki
University of Wollongong, adalecki@uow.edu.au
Frederik Freudenstein
University of Wollongong, frederik@uow.edu.au
Rodney J. Croft
University of Wollongong, rcroft@uow.edu.au
Research Online is the open access institutional repository for the University of Wollongong. For further information contact the UOW Library:
research-pubs@uow.edu.au
Publication Details
Verrender, A., Loughran, S., Dalecki, A., Freudenstein, F. & Croft, R. (2018). Can explicit suggestions about the harmfulness of EMF
exposure exacerbate a nocebo response in healthy controls?. Environmental Research, 166 409-417.
Can explicit suggestions about the harmfulness of EMF exposure
exacerbate a nocebo response in healthy controls?
Abstract
2018 Elsevier Inc. While there has been consistent evidence that symptoms reported by individuals who
suffer from Idiopathic Environmental Intolerance attributed to Electromagnetic Fields (IEI-EMF) are not
caused by EMF and are more closely associated with a nocebo effect, whether this response is specific to IEI-
EMF sufferers and what triggers it, remains unclear. The present experiment tested whether perceived EMF
exposure could elicit symptoms in healthy participants, and whether viewing an 'alarmist' video could
exacerbate a nocebo response. Participants were randomly assigned to watch either an alarmist (N = 22) or
control video (N = 22) before completing a series of sham and active radiofrequency (RF) EMF exposure
provocation trials (2 open-label, followed by 12 randomized, double-blind, counterbalanced trials). Pre- and
post-video state anxiety and risk perception, as well as belief of exposure and symptom ratings during the
open-label and double-blind provocation trials, were assessed. Symptoms were higher in the open-label RF-
ON than RF-OFF trial (p <.001). No difference in either symptoms (p =.183) or belief of exposure (p =.144)
was observed in the double-blind trials. Participants who viewed the alarmist video had a significant increase
in symptoms (p =.041), state anxiety (p <.01) and risk perception (p <.001) relative to the control group.
These results reveal the crucial role of awareness and belief in the presentation of symptoms during perceived
exposure to EMF, showing that healthy participants exhibit a nocebo response, and that alarmist media
reports emphasizing adverse effects of EMF also contribute to a nocebo response.
Publication Details
Verrender, A., Loughran, S., Dalecki, A., Freudenstein, F. & Croft, R. (2018). Can explicit suggestions about
the harmfulness of EMF exposure exacerbate a nocebo response in healthy controls?. Environmental
Research, 166 409-417.
This journal article is available at Research Online: https://ro.uow.edu.au/sspapers/3960
1 
 
Can explicit suggestions about the harmfulness of EMF exposure 
exacerbate a nocebo response in healthy controls? 
 
Adam Verrender a, b*, Sarah P. Loughran a, b, c, Anna Dalecki b, c, Frederik Freudenstein a, b, c, 
Rodney J. Croft a, b, c  
a Australian Centre for Electromagnetic Bioeffects Research 
b School of Psychology, Illawarra Health & Medical Research Institute, University of 
Wollongong, Wollongong, Australia  
c Population Health Research on Electromagnetic Energy, Monash University, Melbourne, 
Australia 
 
Adam Verrender: av138@uowmail.edu.au Bachelor of Psychology (Honours) 
Sarah P. Loughran: loughran@uow.edu.au Doctor of Philosophy 
Anna Dalecki:  adalecki@uow.edu.au  Doctor of Philosophy 
Frederik Freudenstein: frederik@uow.edu.au  Doctor of Philosophy  
Rodney J. Croft:  rcroft@uow.edu.au  Doctor of Philosophy 
 
*Corresponding author: Adam Verrender.  Australian Centre for Electromagnetic Bioeffects 
Research, Illawarra Health and Medical Research Institute, Bld 32.113, University of 
Wollongong, Northfields Ave, Wollongong, NSW, 2522, Australia 
Tel: +612 4239 2118; Fax: +612 4221 8130; Email: av138@uowmail.edu.au  
 
  
2 
 
Abstract 
While there has been consistent evidence that symptoms reported by individuals who suffer 
from Idiopathic Environmental Intolerance attributed to Electromagnetic Fields (IEI-EMF) 
are not caused by EMF and are more closely associated with a nocebo effect, whether this 
response is specific to IEI-EMF sufferers and what triggers it, remains unclear. The present 
experiment tested whether perceived EMF exposure could elicit symptoms in healthy 
participants, and whether viewing an ‘alarmist’ video could exacerbate a nocebo response. 
Participants were randomly assigned to watch either an alarmist (N = 22) or control video (N 
= 22) before completing a series of sham and active radiofrequency (RF) EMF exposure 
provocation trials (2 open-label, followed by 12 randomized, double-blind, counterbalanced 
trials). Pre- and post-video state anxiety and risk perception, as well as belief of exposure and 
symptom ratings during the open-label and double-blind provocation trials, were assessed. 
Symptoms were higher in the open-label RF-ON than RF-OFF trial (p < .001). No difference 
in either symptoms (p = .183) or belief of exposure (p = .144) was observed in the double-
blind trials. Participants who viewed the alarmist video had a significant increase in 
symptoms (p = .041), state anxiety (p <.01) and risk perception (p < .001) relative to the 
control group. These results reveal the crucial role of awareness and belief in the presentation 
of symptoms during perceived exposure to EMF, showing that healthy participants exhibit a 
nocebo response, and that alarmist media reports emphasizing adverse effects of EMF also 
contribute to a nocebo response.  
Keywords: 
Electromagnetic hypersensitivity; Idiopathic environmental intolerance attributed to 
electromagnetic fields (IEI-EMF); Media reports; Medically unexplained symptoms 
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1. Introduction 
The public’s perception of the potential health implications associated with the use of modern 
technologies has been steadily changing in recent years (Petrie et al., 2001; Petrie & Wessely, 
2002). This is often reflected in the mainstream media, where news reports consistently 
suggest that there are dangers of various aspects of modern life while often neglecting more 
mundane causes of illness (Frost, Frank, & Maibach, 1997; Petrie & Wessely, 2002). 
Generally, these stories do not reflect the current state of science (Claassen, Smid, 
Woudenberg, & Timmermans, 2012; Eldridge-Thomas & Rubin, 2013), but instead focus on 
reports of members of the community who claim to experience conditions characterized by a 
variety of adverse symptoms which they ascribe to their use of, or proximity to, various 
environmental stimuli, including vaccinations, genetically modified food, infrasound from 
wind turbines and electromagnetic fields (EMF) emitted by mobile phone and wireless 
technologies (Petrie & Wessely, 2002).  
One particularly prominent condition is Idiopathic Environmental Intolerance attributed to 
Electromagnetic Fields (IEI-EMF). People who suffer from this condition typically report 
experiencing a diverse range of non-specific symptoms which they attribute to their exposure 
to the EMF emitted by everyday electrical and wireless technologies and infrastructure 
(Baliatsas, Van Kamp, Lebret, & Rubin, 2012; Röösli, Moser, Baldinini, Meier, & Braun-
Fahrländer, 2004). Yet, while a considerable proportion of the population report experiencing 
IEI-EMF (estimated to be between 1.5 – 13.5% (Baliatsas et al., 2015; Blettner et al., 2009; 
Eltiti, Wallace, Zougkou, et al., 2007; Hillert, Berglind, Arnetz, & Bellander, 2002; Levallois, 
Neutra, Lee, & Hristova, 2002; Schreier, Huss, & Röösli, 2006; Schröttner & Leitgeb, 2008; 
Tseng, Lin, & Cheng, 2011)), there has been no robust evidence to implicate a 
bioelectromagnetic mechanism in producing the reported symptoms (Health Canada, 2015; 
Health Council of the Netherlands, 2009; Röösli, Frei, Mohler, & Hug, 2010; Rubin, Das 
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Munshi, & Wessely, 2005; Rubin, Nieto-Hernandez, & Wessely, 2010; Scientific Committee 
on Emerging and Newly Idenified Health Risks, 2015; Staudenmayer, Binkley, Leznoff, & 
Phillips, 2003). For instance, when tested under double-blind protocols, IEI-EMF participants 
do not report an increase in symptoms to EMF and are unable to perceive the difference 
between active and sham exposures (Röösli et al., 2010; Rubin et al., 2010). Instead, the 
evidence suggests that the condition is more closely associated with a nocebo response, as 
awareness of the exposure and a belief of being exposed have been shown to play an 
important role in the presentation of the condition. For example, a number of studies have 
found that participants experience an increase in symptoms when they are aware of the active 
exposure condition in an initial non-blinded trial compared to sham, but do not exhibit more 
symptoms in active than sham exposures in subsequent double-blind trials (Eltiti, Wallace, 
Ridgewell, et al., 2007; van Moorselaar et al., 2017; Verrender et al., 2018). Furthermore, 
sham exposures (ie. with no EMF) have been shown to be sufficient to trigger symptoms in 
IEI-EMF participants (Nam et al., 2009; Oftedal, Straume, Johnsson, & Stovner, 2007; 
Verrender et al., 2018; Wilén, Johansson, Sandström, Kalezic, & Lyskov, 2006). The exact 
role of the nocebo response in the development of IEI-EMF, however, is not fully 
understood. For instance, recent findings from a qualitative study suggest that instead of the 
condition originating from a nocebo response, IEI-EMF individuals may be using the notion 
of sensitivity to EMF to provide a narrative to explain their pre-existing medically 
unexplained symptoms, in an effort to make their condition more practically and emotionally 
manageable Dieudonné (2016). Yet, it is important to note that Dieudonné (2016) did not test 
the cause of the participants symptoms, but rather, retrospectively asked participants about 
their beliefs regarding the cause of their symptoms. As retrospective self-reports are known to 
suffer from recall bias (Baliatsas et al., 2015; Vrijheid et al., 2009), these  methods are not 
able to determine symptom etiology.  
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Given the prevalence of distressing and debilitating IEI-EMF symptoms, and in light of the 
evidence suggesting that such symptoms may be the result of a nocebo response, there is a 
great need to better understand the triggers that elicit such responses. Generally, a nocebo 
response occurs when conscious or subconscious negative expectations trigger or exacerbate 
adverse symptoms in response to an exposure that is not known to cause those effects 
(Bräscher, Kleinböhl, Hölzl, & Becker, 2017; Hahn, 1997). These expectations may be 
induced by explicit suggestions about the potential effects of an exposure (Benedetti, Lanotte, 
Lopiano, & Colloca, 2007; Webster, Weinman, & Rubin, 2016) or by learning through 
classical conditioning (Bräscher, Kleinböhl, et al., 2017).  
The communication of information about potential adverse health effects associated with 
EMF exposure constitutes an explicit suggestion which may be responsible for the formation 
of negative expectations and consequent nocebo response seen in IEI-EMF individuals 
(Webster et al., 2016). For example, there has been consistent evidence that precautionary 
information can negatively influence beliefs about EMF exposure, despite this information 
originally being intended to reassure the public (Barnett, Timotijevic, Shepherd, & Senior, 
2007; Nielsen et al., 2010; Wiedemann, Boerner, & Repacholi, 2014; Wiedemann et al., 
2013; Wiedemann & Schütz, 2005; Wiedemann, Thalmann, Grutsch, & Schütz, 2006). 
Similarly, viewing mainstream media reports which either promote the view that EMF 
exposure is hazardous, or focus on individuals with IEI-EMF, have been shown to increase 
worries about EMF exposure (Witthöft et al., 2017), while viewing an advertisement 
claiming to protect against the ‘harmful effects of everyday EMF exposure’ has been shown 
to increase both heart rate and concern about EMF (Köteles, Tarján, & Berkes, 2016). 
Further, recent content analyses have shown that mainstream media reports about EMF 
exposure often misrepresent the current state of scientific evidence by focusing on an 
electromagnetic cause for IEI-EMF, or suggesting a relationship between EMF exposure and 
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ill-health (Claassen et al., 2012; Eldridge-Thomas & Rubin, 2013). If such misinformation is 
being distributed on a wide scale and is negatively influencing people’s beliefs about EMF 
exposure, it is possible that this may be a contributing factor to the prevalence of IEI-EMF. 
Yet, it remains unclear whether the negative beliefs induced by such communications can 
result in greater symptom formation following a perceived exposure to EMF. Although 
Szemerszky, Köteles, Lihi, and Bárdos (2010) demonstrated that suggestions about the 
strength of EMF exposure can lead to increased symptom scores and an increase in the belief 
that a sham magnetic field was active, that study did not assess the effect of explicit 
suggestions of risk from EMF exposure (which may induce negative expectations) and was 
limited by a lack of counterbalancing. Furthermore, while Witthöft and Rubin (2013) 
reported that viewing a sensationalist media report about the adverse effects of Wi-Fi can 
increase the likelihood of a person experiencing symptoms following a sham exposure and 
developing an apparent sensitivity to EMF, the effect was only found for those with high pre-
existing levels of state anxiety. This may be because the study lacked a verified non-exposure 
condition, potentially resulting in insufficient statistical power to detect effects in non-
anxious individuals. In support of this notion, a similar study which included a cued non-
exposure condition found that those who watched a film focusing on ‘adverse effects of Wi-
Fi’ perceived tactile electrical stimuli as more intense during a cued Wi-Fi exposure (which 
was actually a sham exposure) compared to a cued no Wi-Fi condition, and that the effect 
was not mediated by anxiety (Bräscher, Raymaekers, Van den Bergh, & Witthöft, 2017). This 
suggests that manipulating a participant’s belief of exposure via cues may be important for 
influencing symptom perception irrespective of pre-existing state anxiety levels. The latter 
study, however, assessed somatosensory perception rather than symptom perception, and so it 
remains uncertain as to whether negative beliefs induced by information about EMF exposure 
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can result in greater symptom formation or belief regarding exposure status following a 
perceived exposure to EMF.   
To address these limitations, the present study was designed to determine whether perceived 
EMF exposure could elicit symptoms in a healthy population, and additionally, whether 
messages emphasizing ‘adverse health effects of EMF exposure’ can exacerbate a nocebo 
response. The study was also designed to explore, within-subjects, whether there is a 
relationship between a person’s belief of exposure and symptoms, and whether there is a 
difference in symptom response between participants with low, medium and high pre-existing 
levels of state anxiety. To this end, an initial non-blinded open-label trial was employed, 
where the status of exposures emanating from the device (during an active and sham 
condition) were visually demonstrated to each participant using an EMF meter.  
2. Materials and Methods 
2.1 Participants 
Forty-four participants aged 18 – 30 years (M = 21.92, SD = 4.88; 50% male) were recruited 
through advertisements placed online and around the University of Wollongong campus. A 
power calculation conducted in G*Power 3.0 (Faul, Erdfelder, & Buchner, 2007) for an 
independent samples t test based on an effect size of 0.8, an alpha level of .05 and a power of 
0.80 recommended a total sample size of 42.  
All participants were first screened via a telephone interview to confirm eligibility for the 
study. To be included in the study, participants were required to be over the age of 18 and 
report being of good health. Participants were excluded from the study if they reported 
having a current illness or medical condition, or having used illicit substances within the 7-
day period prior to the study. Suitable participants were required to attend the Illawarra 
Health and Medical Research Institute for one mutually convenient testing session. The study 
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was approved by the Human Research Ethics Committee (HE: 2016/981). All participants 
were instructed to abstain from alcohol for at least 8 h, caffeine for at least 1 h, and mobile 
phone use for at least 2 h before the beginning of the testing session. Participants were 
compensated with a monetary gift card for their involvement in the study.  
2.2 Radiofrequency exposure 
RF exposure was generated using a portable, self-contained, battery-operated device (Two 
Fields Consulting, St Kilda, Australia). The RF device was placed 30 cm to the left side of 
the participant (at approximately shoulder to head height) on a hard surface. The main 
exposure from the device was a spread spectrum RF signal in the 902-928 MHz ISM band 
which was digitally modulated in a similar manner to signals from Wi-Fi and 3G/4G mobile 
phones. The RF signal was generated by a commercial RF modem which emitted a frequency 
hopping spread spectrum signal with an average radiated power output of 1 W for 10 min 
(RF-ON), or was completely EMF silent (RF-OFF, sham trials). The incident RF exposure 
level from the side of the device facing the participant was measured using a calibrated 
broadband instrument with an uncertainty of ± 2.4 dB for a two-sided coverage interval and a 
coverage factor of 2 (Narda EMR 300 meter and Type 9 E-field probe, Narda Safety Test 
Solutions, Hauppauge, NY), and was found to be 0.3 W/m². This RF exposure level is below 
the power density reference level limit of 4.6 W/m² specified for the Australian general 
public (ARPANSA RPS3) and by the International Commission on Non-Ionizing Radiation 
Protection (ICNIRP, 1998). It is important to note that the maximum localized specific 
absorption rate (SAR) from the exposure device used in the present study is less than that 
induced from personal mobile phone use (held against the ear in the active talk mode) due to 
the greater separation distance. Conversely, the whole body averaged SAR and localized 
SAR of the device are greater than those normally produced by Wi-Fi and mobile phone base 
station signals. The device was fully enclosed in a thermally insulated case and coded inputs 
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were used to maintain double-blinding. The device contained an independent RF monitor to 
check the status of the RF transmitter and each use of the device was logged using internal 
memory.  
2.3 Questionnaires 
2.3.1 Symptoms and exposure status scale (SESS) 
During the provocation trials, participants were asked to indicate whether they believed the 
exposure was on or off, and to rate whether they were experiencing any symptoms via pen 
and paper 100 mm visual analogue scales. To assess belief of exposure, participants were 
asked “how sure are you of the current exposure status right now?” anchored with the terms 
‘Definitely OFF’ and ‘Definitely ON’. To assess symptom experience, a modified state 
version of the 34 item Checklist for Symptoms in Daily Life (Wientjes & Grossman, 1994; 
Witthöft & Rubin, 2013) was used. Participants were asked “how strong/unpleasant are the 
following symptoms right now?” anchored with the terms ‘Barely Detectable’ and 
‘Maximum Severity’. These response categories differed from the original questionnaire 
(Wientjes & Grossman, 1994) and were used in line with our previous study (Verrender et al., 
2018). The symptom responses of the 34 items were added to calculate a total symptom score 
for each of the baseline and exposure intervals in each trial. The primary dependent variables 
for belief of exposure and symptoms in the provocation trials were calculated as difference 
scores between the baseline and exposure questionnaires (exposure interval minus preceding 
baseline) given during each trial (see procedure below); a difference score was used to 
minimize the influence of baseline variability and potential carry-over effects. 
2.3.2 Risk perception questionnaire (RPQ) 
A self-generated risk perception questionnaire comprising 4 questions was used to assess 
EMF risk perception. Question 1 assessed concerns about electromagnetic fields in general 
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and question 2 assessed concerns about electromagnetic fields in relation to mobile phones 
and Wi-Fi. Participants were asked “How concerned are you about the potential health risks 
of electromagnetic fields in general?” rated on a 7-point Likert scale (1 = not worried at all, 7 
= very worried) and “All in all, how threatened do you feel by electromagnetic radiation 
emissions from mobile phones and Wi-Fi?” rated on a 7-point Likert scale (1 = not 
threatening at all, 7 = very threatening). To enable standardized measurement of RF-EMF 
risk perception in relation to mobile phones and Wi-Fi, questions 3 and 4 used picture-guided 
scenarios which illustrated everyday exposure situations (Freudenstein, Wiedemann, & 
Brown, 2015). Participants were asked “How dangerous do you think the electromagnetic 
fields from mobile phones are while you talk on the phone, as illustrated in this picture?” and 
“How dangerous do you think the electromagnetic fields are from Wi-Fi routers in close 
proximity, as illustrated in this picture?” rated on a 7-point Likert scale (1 = not dangerous at 
all, 7 = very dangerous). The RPQ score was defined as the mean score from all responses. 
2.3.3 State and Trait Anxiety Index (STAI) 
The 40 item version of the STAI (Spielberger, Gorsuch, & Lushene, 1970) was used to assess 
participant’s state and trait anxiety. This comprises two, 20-item forms, assessing state 
(STAI-Y1) and trait (STAI-Y2) anxiety separately, with items answered on a 4-point Likert 
scale (1 = not at all, 4 = very much so). Low, medium and high anxiety were defined as the as 
being less than minus 1 standard deviation from the mean, between minus 1 standard 
deviation and plus 1 standard deviation from the mean, and greater than plus 1 standard 
deviation from the mean respectively (Witthöft & Rubin, 2013). 
2.3.4 NEO Five Factor Personality Index (NEO FFI) 
The 60 item NEO FFI (Costa & McCrae, 1992) was used to assess personality traits: 
Extraversion, Agreeableness, Conscientiousness, Neuroticism, and Openness to Experience. 
This measure is beyond the scope of this paper and will not be discussed further. 
12 
 
2.4 Design 
In an experimental between-groups design, participants were assigned to the alarmist or 
control video group by a computerized random allocation process. In the alarmist video 
group, participants viewed a 3 min video appeal to the United Nations from a concerned 
scientist asking that more precautionary action be taken in regard to EMF exposure “from our 
favorite gadgets.” This included statements about the potential health risks from mobile 
phone and Wi-Fi signals, as well as sensationalized images of exposure scenarios (Blank, 
2015). In the control group, participants viewed a 3 min segment of a documentary on gravity 
(Cox, 2013). This video contained no health related content. To minimize the influence of 
experimenter bias, a researcher not involved in data collection (AD) was responsible for the 
randomization and administration of the videos. 
For the provocation trials, a randomized, counterbalanced, cross-over design was employed. 
Each participant’s symptoms and belief of exposure was tested under a series of 14 sham and 
active provocation trials. The first two trials were non-blinded, open-label trials (1 RF-OFF, 1 
RF-ON), where both the participant and the researcher were aware of the exposure status. 
This was verified to the participant using a Nardalert S3 broadband monitor (Narda Safety 
Test Solutions, Hauppauge, NY). These trials were followed by a series of 12 double-blind, 
randomized, counterbalanced trials (6 sham, 6 RF-ON). Randomization and counterbalancing 
was achieved using Excel (randomization command), such that a sham and RF-ON condition 
were treated as a pair; the conditions for each pair were randomly allocated before assigning 
the next pair; and no more than three of the same pair-order were permitted.  
2.5 Procedure 
A participant information sheet was sent to people who responded to recruitment flyers. This 
informed participants that a small percentage of the population report being sensitive to EMF, 
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described some of the symptoms reported by IEI-EMF sufferers and explained that although 
the scientific evidence has yet to establish a clear relationship between exposure and 
symptoms, news reports about the possible adverse health effects of RF exposure continue to 
focus on people who report these symptoms. The general aims of the study were also listed in 
the information sheet.  
Following a telephone screening interview, suitable participants were booked in for one 
mutually convenient testing session starting at 09:00 am, which lasted approximately 5.5 h. 
Upon arrival at the laboratory, participants provided informed written consent and were given 
a verbal briefing of the ensuing testing session. After being instructed to switch off and leave 
all electronic devices in a general area of the laboratory, participants were then seated 
comfortably inside a Faraday cage, where they completed the baseline (Time 1 (T1)) 
measures of the STAI and RPQ. After completing the T1 questionnaires, participants then 
watched one of the two videos (based on their randomly assigned group). To maximize 
attention, participants were instructed to pay attention to the video as they would be required 
to answer questions about the video as part of a memory test at the conclusion of the study 
(although no memory test was conducted). After watching the video, participants again 
completed the STAI and RPQ (Time 2 (T2)). The exposure device was then set up and the 
provocation trials commenced, beginning with the initial 2 open-label trials (1 RF-OFF, 1 
RF-ON), followed by the 12 double-blind trials. Each of the provocation trials lasted 20 min, 
beginning with a 5 min baseline interval, followed by a 10 min exposure interval (RF-ON or 
RF-OFF/sham, depending on randomization and counterbalancing), and concluded with a 5 
min rest interval before the onset of the next trial. In each trial, participants were required to 
complete the SESS 2.5 mins into the baseline interval and again 7 mins into the exposure 
interval. At the conclusion of the provocation trials, participants were led out of the Faraday 
cage and asked whether they had any questions or concerns about any aspect of the 
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experiment. No participants reported any concern about the experiment. A 15 min break was 
given after the 8th provocation trial. 
2.6 Statistical analyses 
Statistical analyses were performed with SPSS Statistics for Windows, Version 23.0 (IBM, 
Armonk, New York). Where normality tests and visual inspection of the data revealed 
violations to the assumption of normality, non-parametric tests were employed and the 
corresponding effect sizes (ES) were calculated as r, (where 0.1 = small, 0.3 = medium and 
0.5 = large (Cohen, 1988)). Where parametric tests were conducted, corresponding effect 
sizes were calculated as Cohen’s d, (where 0.3 = small, 0.5 = medium and 0.8 = large 
(Cohen, 1988)). 
2.6.1 Preliminary Analyses:   
Independent samples t tests were used to compare pre-existing (T1) levels of state anxiety 
(STAI-Y1), trait anxiety (STAI-Y2) and risk perception (RPQ) between the control and 
alarmist video groups. A Wilcoxon Signed-Ranks test was used to determine whether 
participants understood the exposure protocol by assessing whether there was a difference in 
belief of exposure rating of the SESS between the RF-OFF and RF-ON open-label trials.  
2.6.2 Hypothesis Driven Analyses:  
A Wilcoxon Signed-Ranks test was used to determine whether there was a main effect of 
exposure on the symptom score of the SESS in the open-label trials. To assess whether there 
was an interaction between video group and symptom score, a symptom difference score 
(RF-ON minus RF-OFF) was calculated and a Mann-Whitney U test used to compare the 
difference score between control and alarmist video groups in the open-label trials.  
2.6.3 Exploratory Analyses:  
To verify whether there was no effect of RF-EMF exposure, Wilcoxon Signed-Ranks tests 
were used to determine whether there was a main effect of exposure on either the belief of 
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exposure rating or the symptom score of the SESS in the double blind trials. To assess 
whether there was an interaction between video group and either belief of exposure rating or 
symptom score, a difference score for each variable was calculated (RF-ON minus RF-OFF). 
These difference scores were calculated by averaging the belief of exposure, and separately 
the symptom difference scores (already calculated as the difference between the baseline and 
exposure intervals) of each variable across the 6 RF-ON and 6 RF-OFF conditions. The 
averaged RF-ON score was then subtracted from the averaged RF-OFF score. Mann-Whitney 
U tests were then used to compare each of these variables between the control and alarmist 
video groups.  
Spearman’s rho measure of association was used to test whether there was a relationship 
between belief of exposure and symptoms in the double-blind trials (irrespective of actual 
exposure condition) for each individual participant. The resultant rho values were then 
transformed using a Fisher transformation, and a one sample t test was used to determine 
whether these transformed correlations differed from 0.  An independent samples t test was 
used to assess whether there was a difference in the Fisher transformed Spearman’s rho 
values between the control and alarmist video groups. 
Mann-Whitney U tests were used to assess whether the difference between T1 and T2 STAI-
Y1 score, and separately RPQ score, differed between the control and alarmist video groups.  
A  Jonckheere-Terpstra test was used to determine whether there was a linear trend in the 
symptom score of the RF ON open-label trial as a function of pre-existing state anxiety.   
 
3. Results 
3.1 Preliminary Analyses 
The means, standard deviations and test statistics for assessing whether there were significant 
differences between the control and alarmist video groups in relation to pre-existing levels of 
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state anxiety (STAI Y-1), trait anxiety (STAI – Y2) and risk perception (RPQ) are displayed 
in Table 1. No significant differences were detected. Verifying that participants understood 
the exposure protocol (they believed that they were being exposed in the RF-ON condition 
and that they were not being exposed in the RF-OFF condition), belief of exposure ratings 
were significantly higher in the RF-ON (Median = 100) compared to the RF-OFF (Median = 
0) condition, T = 0.00, z = - 5.86 (corrected for ties), N – ties = 44, p < .001, ES = 0.88. All 
participants correctly reported that they were confident that the exposure was ‘Definitely ON’ 
in the RF-ON condition and ‘Definitely OFF’ in the RF-OFF condition of the open-label 
trials 
Table 1: Descriptive statistics and tests for differences in pre-existing levels of state anxiety, 
trait anxiety and risk perception between the two video groups.  
M = mean; SD = standard deviation; ES = effect size. 
3.2 Hypothesis Driven Analyses: 
3.2.1 Symptoms in the open-label trials: 
Figure 1 shows the SESS symptom scores for the RF-OFF and RF-ON open-label trials. 
Overall, participants had significantly higher increases in symptom scores in the RF-ON 
Dependent 
variable 
Control video 
N = 22 
Alarmist video 
N = 22 
Test statistic for 
differences between 
groups 
State Anxiety M = 29.00, SD = 8.11 M = 30.45, SD = 9.96 
t(42) = -0.639,  
p = .527, ES = 0.19 
Trait Anxiety M = 38.45, SD = 11.85 M = 36.41, SD = 9.79 
t(42) = -0.624,  
p = .536, ES = 0.19 
Risk Perception M = 2.35, SD = 1.12 M = 2.51, SD = 1.09 
t(42) = - 0.477,  
p = .636, ES = 0.14 
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condition (Median = 17.00) compared to the RF-OFF condition (Median = -0.50), T = 77.00, 
z = -4.476 (corrected for ties), N - ties = 40, p < .001, ES = 0.71.  
3.2.2 Effect of video group on symptoms in the open-label trials: 
The symptom scores in the RF-OFF condition were equal between the alarmist (Mean = 
11.59 Median = -3) and control (Mean = 11.45 Median = 0) video groups, validating the 
comparison of symptom difference scores between the two groups. Figure 2 shows the 
symptom difference score (RF-ON – RF-OFF) for the control and alarmist video groups in 
the open-label trials. The symptom difference score was higher in the alarmist (Median = 
25.50) compared to the control (Median = 5.00) video group, and the interaction between 
symptom difference score and video group was significant, U = 159.50, z = -1.738, p = .041 
(one-tailed), ES = 0.261. 
  
                                                     
1 One significant outlier was removed from this analysis. The interaction between symptom difference score and 
video group only reached trend level when including this outlier, U = 181.50, z = -1.421, p = .078 (one-tailed), 
ES = 0.24. 
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Figure 2: The mean (dot), median (line), interquartile range (box) and range (whiskers) of 
the difference in SESS symptom score (RF-ON – RF-OFF) are shown as a function of video 
group in the open-label trials1. 
Figure 1: The mean (dot), median (line), interquartile range (box) and range (whiskers) of the 
SESS symptom scores are shown for the RF-OFF and RF-ON open-label trials. 
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3.3 Exploratory Analyses 
3.3.1 Effect of exposure on belief of exposure and symptoms in the double-blind trials:	
The SESS belief of exposure ratings in the RF-ON and sham double-blind trials are shown in 
Figure 3. Overall, there was no difference in belief of exposure rating between the RF-ON 
(Median = 34.58) and Sham conditions (Median = 38.33), T = 331.00, z = -1.062 (corrected 
for ties), N – ties = 40, p = .144 (one-tailed), ES = 0.17, indicating that there was no main 
effect of exposure on belief of exposure rating. Three participants correctly identified at 
greater than chance levels (within-subjects), when they were and were not being exposed in 
the double-blind trials, with 1 participant getting 75% correct and 2 participants getting 83% 
correct. No other participants could correctly identify when they were being exposed. Given a 
chance level of 5% and that there were 44 participants, it would be expected that 2.2 
participants would correctly identify the conditions by chance. 
The SESS symptom scores in the RF-ON and sham double-blind trials are shown in Figure 4. 
Overall, there was no difference in symptom score between the RF-ON (Median = 10.33) and 
Sham conditions (Median = 10.33), T = 398.00, z = -0.906 (corrected for ties), N – ties = 43, 
p = .183 (one-tailed), ES = 0.14, indicating that there was no main effect of exposure on 
symptoms.  
Spearman’s rho measure of association showed that the relationships between belief of 
exposure and symptoms in the double-blind trials were highly variable between participants. 
These values ranged from -.276 to .882 in the control video group and -.675 to .852 in the 
alarmist video group. Following a Fisher transformation, a one-sample t test found that the 
transformed rho values were significantly greater than 0, t(43) = 6.862, p < .001, ES = 1.03.   
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3.3.2 Effect of video group on belief of exposure and symptoms in the double-blind trials: 
The belief of exposure difference score (RF-ON – Sham) also not differ between the control 
(Median = -0.33) and alarmist (Median = 4.25) video groups, U = 186.50, z = -1.303, p = 
.096 (one-tailed), ES = 0.20, indicating that there was no interaction between video group and 
belief of exposure rating. The symptom difference score (RF-ON – Sham) also did not differ 
between the control (Median = -1.25) and alarmist (Median = 1.92) video groups, U = 
218.00, z = -0.563, p = .287 (one-tailed), ES = 0.08, indicating that there was no interaction 
between video group and symptoms. 
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Figure 3: The mean (dot), median (line), interquartile range (box) and range (whiskers) of the 
SESS belief of exposure rating are shown for the sham and RF-ON double-blind trials. 
Figure 4: The mean (dot), median (line), interquartile range (box) and range (whiskers) 
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3.3.3 Effect of video on state anxiety and risk perception:  
The difference in state anxiety (STAI-Y1) from T1 to T2 was significantly higher in the 
alarmist (Median = 3.50) compared to the control (Median = -.50) video group, U = 135.50, z 
= -2.505, p <.01 (one-tailed), ES = 0.38. The difference in risk perception (RPQ) from T1 to 
T2 was also significantly higher in the alarmist (Median = 1.00) compared to the control 
(Median = 0.00) video group, U = 75.50, z = -3.946, p < .001 (one-tailed), ES = 0.60.  
3.3.4 Relationship between belief of exposure and symptoms in double-blind trials as a 
function of video group: 
The relationship between belief of exposure and symptoms (Fisher transformed Spearman’s 
rho values) did not differ between the control (M = .47, SD = .48) and alarmist (M = .54, SD 
= .50) video groups, t(42) = -.443, p = .660, ES = 0.07.  
3.3.5 Relationship between pre-existing state anxiety and symptoms in open-label trials: 
Figure 5 shows the SESS symptom scores as a function of anxiety group. No significant trend 
between symptom scores and higher levels of pre-existing anxiety was detected, J = 210.00, z 
= -.838, p = .402, ES = 0.13. 
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4. Discussion 
While there has been growing evidence that the symptoms reported by IEI-EMF sufferers are 
likely the result of a nocebo effect (Eltiti, Wallace, Ridgewell, et al., 2007; Nam et al., 2009; 
Oftedal et al., 2007; van Moorselaar et al., 2017; Verrender et al., 2018; Wilén et al., 2006), 
there has been limited understanding of the factors which contribute to such a response. 
Although a number of studies have shown that explicit suggestions about the adverse effects 
of EMF exposure can increase concern and negatively influence people’s beliefs about EMF 
exposure (Barnett et al., 2007; Köteles et al., 2016; Nielsen et al., 2010; Wiedemann et al., 
2014; Wiedemann et al., 2013; Wiedemann & Schütz, 2005; Wiedemann et al., 2006; 
Witthöft et al., 2017) (factors which are considered to be key in contributing to a nocebo 
response (Webster et al., 2016)), it has remained relatively unclear whether the negative 
Figure 5: The mean (dot), median (line), interquartile range (box) and range (whiskers) of the 
SESS symptom scores in the RF-ON open-label trial are shown as a function of pre-existing 
state anxiety level. 
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beliefs induced by such communications can result in greater symptom formation following a 
perceived exposure to EMF.  The purpose of this experiment was to investigate whether 
perceived EMF exposure would elicit symptoms in a healthy population and to assess 
whether messages that emphasize ‘adverse health effects of EMF exposure’ can induce a 
nocebo response, including for those without high pre-existing levels of state anxiety. In the 
provocation trials, both active and sham EMF exposures were first demonstrated to 
participants in an initial non-blinded, open-label trial, before a series of double-blind, 
randomized, counterbalanced trials were conducted. By demonstrating that the experiment 
contained a ‘no exposure’ condition, the present study was able to more clearly determine 
whether any observed increases in symptoms were the result of a nocebo effect. 
A number of preliminary tests were first used to establish whether the experiment was valid 
and whether the experimental manipulation had worked. These checks demonstrated that 
there were no differences in pre-existing levels of state anxiety, trait anxiety and EMF risk 
perception between the alarmist and control video groups. Further, these tests verified that 
participants understood the exposure protocol, as they correctly indicated that they were 
being exposed in the RF-ON open-label trial and not being exposed in the RF-OFF open-
label trial.  
The results of the provocation trials revealed the crucial role of awareness and belief in the 
presentation of symptoms during perceived exposure to EMF. In the open-label trials, 
participants reported higher symptom scores in the RF-ON trial compared to the RF-OFF 
trial. In the subsequent double-blind trials, however, there was no difference in either belief 
of exposure or symptom scores between the RF-ON and sham conditions. These findings 
demonstrate that knowledge and/or awareness of the exposure condition was essential for 
producing an effect on symptoms. In addition to this, belief of exposure was found to be 
positively associated with higher symptom scores in the double-blind trials, giving further 
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indication that a nocebo effect, rather than EMF exposure itself, was responsible for the 
increase in symptoms. In regards to the effect of messages which emphasize the ‘adverse 
health effects of EMF exposure’, the present study found that participants who viewed the 
alarmist video had higher symptom scores in the open-label trials than participants who 
viewed the control video. While, in contrast to Witthöft and Rubin (2013), the present study 
found that the effect of the video on symptom score was not moderated by pre-existing levels 
of state anxiety, it is important to note that the effect of the video on symptom score in the 
present study was only trend level when including an outlier in the sample. This may indicate 
that the effect of the video was strongly influenced by the individuals in the study. This 
corresponds to the notion that both situational factors (such as viewing a particular media 
report) and dispositional factors (such as personality traits) interact to influence people’s 
worries about the potential health hazards of modern life, though further research is required 
to clarify the personality traits which may be involved in moderating this effect (Witthöft et 
al., 2017). It is important to note, however, that sample size may also play a considerable role 
in the interaction between the type of video viewed and symptom score, and a larger sample 
size would have increased the chance of identifying an effect of the video in the present 
study. In line with previous research, the present study also found  that participants who 
viewed the alarmist video had a larger increase in state anxiety and risk perception from 
baseline relative to those who viewed the control video (Bräscher, Raymaekers, et al., 2017; 
Witthöft et al., 2017; Witthöft & Rubin, 2013). This provides further support to the notion 
that sensationalized media reports are capable of increasing people’s concerns and worries 
about exposure to EMF. Nonetheless, it is also possible that pre-existing beliefs about the 
relative harmfulness of EMF exposure may have influenced the results of this study via a 
ceiling effect. Future studies could usefully address this issue by using pre-screening to 
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allocate participants into “high” and “low” risk perception groups, within each of the control 
and alarmist video groups. 
Overall, the results of the present study corroborate those of IEI-EMF provocation studies, 
and demonstrate that the belief of being exposed, rather than EMF exposure itself, is 
sufficient to trigger symptoms in healthy participants, including those without high pre-
existing levels of anxiety. This is supported by the fact that 77% of participants reported 
higher symptoms in the open-label RF-ON trial compared to the RF-OFF trial, while no 
difference in symptom score was detected in the double-blind trials. Although the size of the 
effect on symptoms in the open-label trials in the present study was not as large as the effect 
observed for IEI-EMF sufferers in a previous study (ES > 3.6)(Verrender et al., 2018) , the 
effect observed in the present study was still quite large (ES = 0.71), and is larger than the 
traditionally used nomenclature of Cohen (1988) (who treats the largest category of effect 
size as >.05). This may indicate that the nocebo response displayed by IEI-EMF sufferers 
during a perceived exposure situation is a normal human response. In addition to this, the 
results of the present study not only support those of previous studies suggesting that 
sensationalist media reports about perceived environmental hazards can raise concerns and 
negative beliefs about EMF, but also demonstrate that such reports may be contributing to a 
symptomatic nocebo response. This is analogous to the conclusions reached by studies 
investigating whether media health warnings can influence symptom expectations after 
exposure to infrasound from wind turbines or chemical pollution (Crichton, Dodd, Schmid, 
Gamble, & Petrie, 2014; Winters et al., 2003) and further emphasizes the importance of 
disseminating accurate scientific and health information in order to reduce the likelihood of 
symptomatic nocebo responses in the community more generally.  
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A number of potential limitations should be considered when interpreting the results of the 
present study. First, as the sample was mainly comprised of a relatively young healthy 
population, the present study is unable to comment on whether similar effects of alarmist 
media would be observed in a more general population sample. While online advertisements 
were used in an attempt to attract greater interest in the study, future studies could address 
this issue by using local newspapers and radio stations to recruit more broadly from the 
community. Second, as the RF-OFF condition always preceded the RF-ON condition in the 
open-label trials, the possibility that part of the increase in symptoms in the open-label trials 
(independent of the media content) was due to the elapsed study time cannot be completely 
ruled out. However, it is important to note that participants in provocation studies generally 
do not report such large increases in symptoms as a function of time (Schmidt, Wolfs-Takens, 
Oosterlaan, & van den Hout, 1994). In addition to this, it is possible that effects on risk 
perception and symptoms may be triggered by any message on EMF and health, irrespective 
of whether it is an alarmist or positive message. However, Crichton and Petrie (2015a) found 
that positively framed health information may reverse or dilute the effect of negative 
expectations formed by alarmist media in the context of infrasound exposure, which suggests 
that the frame of the message is important for symptom perceptions. Nevertheless, future 
studies could include a third ‘positive’ video group to address this issue. Finally, due to 
feasibility requirements, the present study was limited to assessing acute symptom responses 
to acute exposures and the experiment was conducted in a laboratory setting using a Faraday 
cage. It is important that these factors are taken into consideration when interpreting the 
results of the present study, as these conditions may not reflect typical everyday exposure 
scenarios.   
Although the present study has provided further evidence that symptoms attributed to EMF 
exposure are likely the result of a nocebo response, one of the major difficulties in treating 
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IEI-EMF is the stigma attached to the notion that the condition is a psychological illness. 
While cognitive-behavioral therapy has been shown to be efficacious in treating IEI-EMF 
(Rubin, Das Munshi, & Wessely, 2006), simply telling sufferers that their symptoms do not 
have a toxicological cause is not reassuring and is unlikely to completely alleviate symptoms 
(Rief, Heitmüller, Reisberg, & Rüddel, 2006). For instance, although van Moorselaar et al. 
(2017) found that providing individual feedback on the results of double-blind provocation 
studies reduced IEI-EMF participants certainty about responding to acute EMF exposures, the 
feedback did not materially change IEI-EMF sufferers perception of being sensitive to EMF 
in their everyday life.  Likewise, Nieto-Hernandez, Rubin, Cleare, Weinman, and Wessely 
(2008) found that providing feedback to IEI-EMF sufferers about their ability to discriminate 
between active and sham exposures had no influence on subsequent symptom levels or 
perceived sensitivity to EMF. Explaining the nocebo response may, however, offer an 
alternative solution. Recently, Crichton and Petrie (2015b) found that participants who 
reported symptomatic experiences during infrasound exposure returned mood and symptom 
levels to baseline levels in a subsequent exposure after they had received an explanation of 
the nocebo response with supporting scientific evidence. Whether such an effect could be 
replicated in people who experience IEI-EMF, however, remains unclear. Explaining that the 
nocebo response experienced by IEI-EMF sufferers is a normal human response may also 
offer a useful approach for addressing the condition in the future. Nonetheless, it is 
conceivable that explaining psychological mechanisms to people who claim to experience 
IEI-EMF may be interpreted as offensive or lacking credibility. It may thus be more 
appropriate (and more accurate) to emphasize that although EMF has not been shown to 
cause symptoms, that this does not mean that IEI-EMF symptoms are necessarily due to the 
nocebo effect; they may also relate to an undiagnosed medical condition (Dieudonné, 2016) 
which would require attention from a medical professional. Discussing the potential etiology 
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of symptoms with IEI-EMF sufferers is thus a difficult task, and one that requires further 
investigation.  
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